EKTA B Stock Overview
Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||kr70.66|
|52 Week High||kr132.35|
|52 Week Low||kr62.60|
|1 Month Change||-7.03%|
|3 Month Change||-8.45%|
|1 Year Change||-43.11%|
|3 Year Change||-47.54%|
|5 Year Change||-10.61%|
|Change since IPO||417.02%|
Recent News & Updates
When Should You Buy Elekta AB (publ) (STO:EKTA B)?
While Elekta AB (publ) ( STO:EKTA B ) might not be the most widely known stock at the moment, it received a lot of...
Elekta (STO:EKTA B) Seems To Use Debt Quite Sensibly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
|EKTA B||SE Medical Equipment||SE Market|
Return vs Industry: EKTA B underperformed the Swedish Medical Equipment industry which returned -35.8% over the past year.
Return vs Market: EKTA B underperformed the Swedish Market which returned -22.4% over the past year.
|EKTA B volatility|
|EKTA B Average Weekly Movement||5.7%|
|Medical Equipment Industry Average Movement||8.2%|
|Market Average Movement||7.4%|
|10% most volatile stocks in SE Market||12.3%|
|10% least volatile stocks in SE Market||4.7%|
Stable Share Price: EKTA B is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: EKTA B's weekly volatility (6%) has been stable over the past year.
About the Company
Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems.
Elekta Fundamentals Summary
|EKTA B fundamental statistics|
Is EKTA B overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EKTA B income statement (TTM)|
|Cost of Revenue||kr9.11b|
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
Jul 08, 2022
|Earnings per share (EPS)||3.02|
|Net Profit Margin||7.93%|
How did EKTA B perform over the long term?See historical performance and comparison
3.4%Current Dividend Yield
Does EKTA B pay a reliable dividends?See EKTA B dividend history and benchmarks
|Elekta dividend dates|
|Ex Dividend Date||Aug 26 2022|
|Dividend Pay Date||Sep 01 2022|
|Days until Ex dividend||56 days|
|Days until Dividend pay date||62 days|
Does EKTA B pay a reliable dividends?See EKTA B dividend history and benchmarks
Is EKTA B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EKTA B?
Other financial metrics that can be useful for relative valuation.
|What is EKTA B's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does EKTA B's PE Ratio compare to its peers?
|EKTA B PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
ARJO B Arjo
GETI B Getinge
ELOS B Elos Medtech
EKTA B Elekta
Price-To-Earnings vs Peers: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the peer average (32.9x).
Price to Earnings Ratio vs Industry
How does EKTA B's PE Ratio compare vs other companies in the European Medical Equipment Industry?
Price-To-Earnings vs Industry: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the Swedish Medical Equipment industry average (36.5x)
Price to Earnings Ratio vs Fair Ratio
What is EKTA B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||23.4x|
|Fair PE Ratio||38.5x|
Price-To-Earnings vs Fair Ratio: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the estimated Fair Price-To-Earnings Ratio (38.5x).
Share Price vs Fair Value
What is the Fair Price of EKTA B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EKTA B (SEK70.66) is trading below our estimate of fair value (SEK168.08)
Significantly Below Fair Value: EKTA B is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: EKTA B is poor value based on its PEG Ratio (1.4x)
Discover undervalued companies
How is Elekta forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EKTA B's forecast earnings growth (16.7% per year) is above the savings rate (0.4%).
Earnings vs Market: EKTA B's earnings (16.7% per year) are forecast to grow faster than the Swedish market (9.6% per year).
High Growth Earnings: EKTA B's earnings are forecast to grow, but not significantly.
Revenue vs Market: EKTA B's revenue (7.6% per year) is forecast to grow faster than the Swedish market (5.5% per year).
High Growth Revenue: EKTA B's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EKTA B's Return on Equity is forecast to be low in 3 years time (17%).
Discover growth companies
How has Elekta performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EKTA B has high quality earnings.
Growing Profit Margin: EKTA B's current net profit margins (7.9%) are lower than last year (9.1%).
Past Earnings Growth Analysis
Earnings Trend: EKTA B's earnings have grown by 10.4% per year over the past 5 years.
Accelerating Growth: EKTA B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: EKTA B had negative earnings growth (-8%) over the past year, making it difficult to compare to the Medical Equipment industry average (6.3%).
Return on Equity
High ROE: EKTA B's Return on Equity (13%) is considered low.
Discover strong past performing companies
How is Elekta's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: EKTA B's short term assets (SEK12.9B) exceed its short term liabilities (SEK11.6B).
Long Term Liabilities: EKTA B's short term assets (SEK12.9B) exceed its long term liabilities (SEK5.8B).
Debt to Equity History and Analysis
Debt Level: EKTA B's net debt to equity ratio (17.2%) is considered satisfactory.
Reducing Debt: EKTA B's debt to equity ratio has reduced from 76.8% to 51.7% over the past 5 years.
Debt Coverage: EKTA B's debt is well covered by operating cash flow (40.3%).
Interest Coverage: EKTA B's interest payments on its debt are well covered by EBIT (10.5x coverage).
Discover healthy companies
What is Elekta current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: EKTA B's dividend (3.4%) is higher than the bottom 25% of dividend payers in the Swedish market (1.65%).
High Dividend: EKTA B's dividend (3.4%) is low compared to the top 25% of dividend payers in the Swedish market (5.33%).
Stability and Growth of Payments
Stable Dividend: EKTA B's dividend payments have been volatile in the past 10 years.
Growing Dividend: EKTA B's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (79.5%), EKTA B's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (203.8%), EKTA B's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gustaf Salford (44 yo)
Mr. Gustaf Salford serves as President and Chief Executive Officer at Elekta AB (publ) since November 26, 2020 and served as its Acting President and Chief Executive Officer since June 2, 2020 until Novemb...
CEO Compensation Analysis
Compensation vs Market: Gustaf's total compensation ($USD1.28M) is about average for companies of similar size in the Swedish market ($USD1.77M).
Compensation vs Earnings: Insufficient data to compare Gustaf's compensation with company performance.
Experienced Management: EKTA B's management team is seasoned and experienced (5.4 years average tenure).
Experienced Board: EKTA B's board of directors are seasoned and experienced ( 11.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: EKTA B insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Elekta AB (publ)'s employee growth, exchange listings and data sources
- Name: Elekta AB (publ)
- Ticker: EKTA B
- Exchange: OM
- Founded: 1972
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: kr26.960b
- Shares outstanding: 382.08m
- Website: https://www.elekta.com
Number of Employees
- Elekta AB (publ)
- Kungstensgatan 18
- Box 7593
- Stockholm County
- 103 93
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/30 00:00|
|End of Day Share Price||2022/06/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.